Funding Opportunity PAR-24-258 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support a Human Tissue and Organ Research Resource program to enable the continued availability of human tissues and organs to biomedical researchers. The overall goal of the research resource is to provide a wide variety of human tissues and organs, both diseased and normal, to investigators. The research resource is expected to facilitate the procurement and preservation of human tissues and organs as well as the distribution of these materials to qualified biomedical researchers.

Notice NOT-AI-24-066 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-25-030 from the NIH Guide for Grants and Contracts. The National Institute on Aging (NIA)invitesR01applicationsthat proposehuman studiesto better understand the mechanisms underlying compensatory gait, posture and molecular changes that contribute to slower walking speed and increased metabolic cost of walking. This Notice of Funding Opportunity (NOFO) encourages interdisciplinary collaborations to design integrative approaches that explore interactions among multiple systems (e.g., skeletal, muscle, tendon, somatosensory and central nervous). This NOFO also encourages innovative approaches such as computational modeling, imaging and sensor technologies, machine learning and artificial intelligence to disentangle compensatory gait alterations with aging that contribute to increased metabolic cost of walking and fatigue. Areas of interest include: 1) mechanisms and effects of central nervous system changes; 2) neuromuscular changes; 3) skeletal muscle bioenergetics 4) computational modeling and simulation; and5) changes in tissue structure and function (e.g., muscle-tendon complex, extracellular matrix).

Notice NOT-OD-24-166 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-165 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-25-063 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity announcement is to generate brain region and cell-type specific microglial protein profiles in the context of HIV and SUD, then use those molecular profiles and interaction networks to establish mechanisms of how HIV-harboring microglia may contribute specifically to neuropathologies encountered with comorbid HIV and SUD.

Notice NOT-DA-26-008 from the NIH Guide for Grants and Contracts

Notice NOT-DC-24-040 from the NIH Guide for Grants and Contracts

Notice NOT-AT-24-052 from the NIH Guide for Grants and Contracts

Notice NOT-NR-24-011 from the NIH Guide for Grants and Contracts

Notice NOT-DK-24-030 from the NIH Guide for Grants and Contracts

Notice NOT-DA-24-038 from the NIH Guide for Grants and Contracts

Notice NOT-TW-24-009 from the NIH Guide for Grants and Contracts

Notice NOT-HS-24-020 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HG-24-028 from the NIH Guide for Grants and Contracts. The National Human Genome Research Institute (NHGRI) solicits applications to support the biennial research conference of the Ethical, Legal and Social Implications (ELSI) Research Community (referred to as the ELSI Congress). The proposed conference will: 1) provide the multidisciplinary ELSI research community with a dedicated conference to come together and share research findings; 2) encourage collaboration across the ELSI research community with particular attention to trainees and early career scholars; and 3) provide a highly accessible format to ensure participation from a broad range of groups interested in ELSI research.

Funding Opportunity PAR-24-274 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) invites grant applications for the Research Specialist Award (R50) specifically for clinician scientists supporting NCI-funded clinical trials research. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional clinician scientists who want to continue to participate in the NCI clinical trials networks through leadership in the 1) development of national clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees and other activities, but not serve as principal investigators of research project grants. These clinician scientists are vital to sustaining the NCI-funded clinical trials enterprise. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others or other sources of support for cancer research career continuity.

Notice NOT-CA-24-097 from the NIH Guide for Grants and Contracts

Notice NOT-CA-24-096 from the NIH Guide for Grants and Contracts

Notice NOT-NS-24-130 from the NIH Guide for Grants and Contracts

Notice NOT-AI-24-073 from the NIH Guide for Grants and Contracts